Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pro-Tac
2024-516608-40-00Phase 3Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Feb 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tacrolimus in Kidney allograft status (RTx) (2 arms), sponsored by Universitätsmedizin Essen. Started Feb 2022; status: completed.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2024-516608-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516608-40-00.